The European Commission is trialling using European open source software to run its internal communications, a spokesperson confirmed to Euractiv. The move comes at a time of growing concern within ...
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Pfizer, NYSE:PFE, has entered a global licensing agreement ...
Per the terms of the agreement, Novavax will receive an upfront payment of $30 million from Pfizer and is eligible to earn up to $500 million in potential development and commercial milestone payments ...
Novavax secures a non-exclusive licensing deal with Pfizer, validating Matrix-M's platform value and shifting NVAX toward a technology provider model. NVAX receives $30M upfront, a potential $500M in ...
Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up to another $500 million in milestone payments. The biotech company said ...
Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine programs. The tech, called Matrix-M, is designed to trigger an immune ...
The Matrix View in Cakewalk is a powerful tool for organizing and triggering musical ideas in a non-linear fashion, ideal for live performances, composing, or experimenting with loops and clips. This ...
Data centers — you can either be for them, linking the term with economic development and AI innovation, or against them, wary of environmental consequences and AI’s reach. Or maybe you’re somewhere ...
Plus: Elon Musk tried to persuade Mark Zuckerberg to invest in OpenAI This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of ...
Ambitious targets drive progress—but how do we know if a target is truly ambitious? This video explores how the FAB Matrix evaluates ambitiousness by comparing proposed targets to business-as-usual ...